Symptom Clusters in Children With Leukemia

Childhood Leukemia Clinical Trial

Official title:

Phenotypic and Genotypic Associations With Symptom Clusters During Childhood Leukemia Treatment

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01708421
• Other study ID #: Pro00037891
• Status: Completed
• Start date: November 2012
• Est. completion date: August 1, 2018

Study information

• Verified date: November 2018
• Source: Duke University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to examine the phenotypic and genotypic characteristics and their associations with symptom clusters experienced during treatment for childhood leukemia.

Description:

A repeated measures research design will evaluate phenotypic and genotypic treatment-related symptom associations experienced by children and adolescents 3-17 years of age with a diagnosis of leukemia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 338
• Est. completion date: August 1, 2018
• Est. primary completion date: August 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 3 Years to 18 Years

Eligibility

Inclusion Criteria:

• Phenotypic and genotypic treatment-related symptom associations will be evaluated in children and adolescents 3-18 years of age with a diagnosis of leukemia.

Exclusion Criteria:

• Children without a definite diagnosis of leukemia will be excluded.

• Children must be able to understand and answer the questions on the questionnaires.

• Children with have a cognitive impairment (e.g. Down syndrome) will not be able to complete the questionnaires and will not be eligible for the study.

Related Conditions & MeSH terms

• Childhood Leukemia
• Leukemia
• Syndrome

Locations

Country	Name	City	State
United States	Duke University Medical Center	Durham	North Carolina
United States	Baylor College of Medicine/ Texas Children's Cancer Center	Houston	Texas
United States	Children's Hospitals & Clinics of Minnesota	Minneapolis	Minnesota
United States	University of Arizona	Tucson	Arizona

Sponsors (1)

Lead Sponsor	Collaborator
Duke University

Country where clinical trial is conducted

United States,